$103 Billion is the total value of PRIMECAP MANAGEMENT CO/CA/'s 335 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | JACOBS SOLUTIONS INC | $683,867,000 | – | 6,303,507 | +100.0% | 0.66% | – | |
| JBHT | New | HUNT J B TRANS SVCS INC | $100,437,000 | – | 642,100 | +100.0% | 0.10% | – |
| New | GSK PLCsponsored adr | $12,982,000 | – | 441,120 | +100.0% | 0.01% | – | |
| TWTR | New | TWITTER INC | $7,045,000 | – | 160,700 | +100.0% | 0.01% | – |
| New | HALEON PLCspon ads | $3,358,000 | – | 551,400 | +100.0% | 0.00% | – | |
| BIOX | New | BIOCERES CROP SOLUTIONS CORP | $1,615,000 | – | 124,059 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LILLY ELI & CO | 42 | Q3 2023 | 10.5% |
| BIOGEN INC. | 42 | Q3 2023 | 6.8% |
| AMGEN INC. | 42 | Q3 2023 | 5.3% |
| MICROSOFT CORP. | 42 | Q3 2023 | 4.2% |
| ADOBE SYSTEMS INCORPORATED | 42 | Q3 2023 | 4.1% |
| TEXAS INSTRS. INC. | 42 | Q3 2023 | 3.5% |
| FEDEX CORP | 42 | Q3 2023 | 3.3% |
| SOUTHWEST AIRLS CO | 42 | Q3 2023 | 3.8% |
| NOVARTIS AG ADR | 42 | Q3 2023 | 2.7% |
| MICRON TECHNOLOGY INC | 42 | Q3 2023 | 2.8% |
View PRIMECAP MANAGEMENT CO/CA/'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NEKTAR THERAPEUTICS | July 07, 2023 | 8,149,876 | 4.3% |
| STANDARD BIOTOOLS INC. | July 07, 2023 | 3,220,917 | 4.1% |
| Calithera Biosciences, Inc. | February 09, 2023 | 401,080 | 8.2% |
| CERUS CORP | January 09, 2023 | 8,849,600 | 5.0% |
| COMSCORE, INC. | January 09, 2023 | 2,883,435 | 3.1% |
| STRATASYS LTD. | December 08, 2022 | 3,176,499 | 4.8% |
| Wave Life Sciences Ltd. | December 08, 2022 | 4,225,908 | 4.9% |
| NN INC | November 09, 2022 | 1,763,640 | 4.0% |
| AXCELIS TECHNOLOGIES INC | October 07, 2022 | 1,649,466 | 5.0% |
| Epizyme, Inc.Sold out | September 08, 2022 | 0 | 0.0% |
View PRIMECAP MANAGEMENT CO/CA/'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
View PRIMECAP MANAGEMENT CO/CA/'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.